Microsurfaced Grafts in Deep Burn Wounds
Part of paid clinical trials in Augusta, Georgia.
- Sponsor
- CellTherX
- Study ID
- NCT04589442
- Phase
- PHASE4
- Status
- Recruiting
Conditions
- Burns
- Wound Heal
Eligibility Criteria
- Sex
- ALL
- Age
- 21 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Split thickness skin graft — BIOLOGICALstandard of care graft
- microsurfaced split thickness skin graft — BIOLOGICALstandard of care graft that has been microsurfaced
Study Details
This study is designed as a prospective, randomized, within subject controlled design to evaluate the effectiveness of Microsurfaced vs Control cadaveric grafts for coverage of acute deep-partial or full-thickness burn wounds to promote wound healing. This study will be performed in 2 parts: Time to wound bed preparedness through 6 weeks (Part A) and wound site healing, graft take and long-term scar outcomes (Part B). Subjects will be treated with both control and microsurfaced cadaveric grafts on adjacent deep-partial or full-thickness burn wounds.
Key Dates
- Start date
- Jan 4, 2021
- Status verified
- Jan 2021
- Primary completion
- Aug 31, 2021
- Completion
- Dec 31, 2021
Study Design
- Enrollment
- 20 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Active Comparator: Standard of Care Dermal GraftStandard of care cryopreserved cadaveric split thickness skin grafts
- Experimental: Standard of Care Dermal Graft - MicrosurfacedMicrosurfaced cryopreserved cadaveric split thickness skin grafts
Primary Outcome Measure
Wound bed prep [ Time Frame: 6 week ]
Central Contacts
- Joan Wilson706-364-2966
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Joseph M Still Research Foundation | Augusta | Georgia | 30909 | Claus Brandigi, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Augusta, GA
By research site
Related Studies
- Safety and Efficacy of realSKIN® to Provide Complete Wound Closure of Burn Wounds as an Alternative to AutograftingPHASE3 · Recruiting · XenoTherapeutics, Inc. · Phoenix, Arizona
- Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal BurnsPHASE2 · Recruiting · Skingenix, Inc. · Phoenix, Arizona
- Micro/Nanobubbles (MNBs) for Treatment of Acute and Chronic WoundsEARLY_PHASE1 · Recruiting · University of California, Irvine · Orange, California
- Pilot Study: KeraStat® Gel for Topical Delivery of Morphine for Management of Non-Healing, Painful Open Wounds and UlcersPHASE4 · Recruiting · The Metis Foundation · San Antonio, Texas